OECD · Health
Italy: Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted
75.90US dollars per person, PPP converted · 2025-22.8% since 2015
OECD dataflow OECD.ELS.HD:HEALTH_PHMC@DF_PHMC_SALES. Pharmaceutical sales: Antiinfectives for systemic use (US dollars per person, PPP converted). Annual figures for Italy from 2011 to 2025.
Every year
| Year | Value (US dollars per person, PPP converted) | Note |
|---|---|---|
| 2025 | 75.9 | |
| 2024 | 82 | |
| 2023 | 77.7 | |
| 2022 | 75.2 | |
| 2021 | 67.7 | |
| 2020 | 65.9 | |
| 2019 | 70.6 | |
| 2018 | 71.5 | |
| 2017 | 84.6 | |
| 2016 | 104.8 | |
| 2015 | 98.3 | |
| 2014 | 54.9 | |
| 2013 | 54.8 | |
| 2012 | 52.4 | |
| 2011 | 52.6 |
Source
Published by OECD, produced by OECD. Licence: OECD terms (CC BY 4.0). Retrieved 2026-11-17.
The dataset for every country, with quality and provenance →
Cite or download
OECD (2026). Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted. Interva. https://interva.co/dataset/oecd-df-phmc-sales-ph-sales-z-j-usd-ppp-ps (accessed 2026-11-21). catalog snapshot 2026-11-17.
Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted in other countries
Rank Italy against its region, see where publishers disagree, or ask a question in plain words on the Interva desk.